ASPECTRUM of precisely defined eating disorders, including

0021-972X/99/$03.00/0 Vol. 84, No. 2 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1999 by The Endocrine Society Impact of Binge Eating on Metabolic and Leptin Dynamics in Normal Young Women* ANN E. TAYLOR, JANE HUBBARD, AND ELLEN J. ANDERSON Reproductive Endocrine Unit and National Center for Infertility Research (A.E.T.), and the Mallinkrodt General Clinical Research Center (J.H., E.J.A.), Massachusetts General Hospital, Boston, Massachusetts 02114 ASPECTRUM of precisely defined eating disorders, including anorexia nervosa, bulimia nervosa, and binge eating disorder, are remarkably common in college age American women (1). Up to 30% of obese Americans seeking weight loss therapy (2 4) and up to 50% of obese adolescent girls (5) meet newly described strict criteria for binge eating disorder (DSM-IV). In addition, an even larger number of Americans exhibit some binge eating behavior that does not meet these strict criteria. In one series, 29.6% of college women presenting to a primary care clinic admitted to binge eating episodes (6). Both binge eating disorder and bingeing behavior are associated with a poorer response to weight loss therapy (3, 7) and poorer glycemic control in adolescent women with diabetes mellitus (8, 9). In addition, some reports suggest that binge eating may be associated with polycystic ovary syndrome (10). Other hormonal and metabolic defects, including hypogonadotropic amenorrhea, hypercortisolism, and insulin resistance, have been clearly described in women with the more severe classic eating disorders, such Received September 14, 1998. Revision received November 4, 1998. Accepted November 10, 1998. Address all correspondence and requests for reprints to: Ann E. Taylor, M.D., Reproductive Endocrine Unit, Massachusetts General Hospital, BHX-5, 55 Fruit Street, Boston, Massachusetts 02114. E-mail aetaylor@partners.org. * This work was supported by Grants R29-HD 033509, P30-HD 28138, and M01-RR01066. ABSTRACT Well defined eating disorders such as anorexia nervosa and bulimia are associated with significant known health risks. Although binge eating behavior is increased in unsuccessfully dieting obese women, other health implications of this common eating pattern are unknown. We hypothesized that ingestion of an entire day s calories at one time in the evening, a common eating practice among Americans, would lead to disruptions in glucose, insulin, and leptin metabolism and in menstrual cyclicity, even in healthy young women. Seven lean women without a history of eating disorders were studied on two occasions separated by one or two menstrual cycles. During one admission, they ate three regular meals plus a snack on each of 3 days. On the other admission, they ate the same number of calories, macronutrient matched to the normal diet, in a single evening meal. Glucose, insulin, and leptin were measured frequently for 12 14 h beginning at 0800 h on the third day of each diet, and an insulin tolerance test was performed while the subjects were fasting on the fourth day. Daily blood samples were obtained until ovulation was documented to assess any impact on menstrual function. Ingestion of an entire day s calories at dinner resulted in a significant increase in fasting glucose levels and a dramatic increase in insulin responses to the evening meal. The diurnal pattern of leptin secretion was altered, such that the gradual rise in leptin from 0800 h observed during the normal diet was abolished, and leptin did not begin to rise during the binge diet until at least 2 h after the evening meal. No changes were demonstrated in insulin sensitivity, follicular growth, or ovulation between the two diets. We conclude that 1) ingestion of a large number of calories at one time (binge eating) impacts metabolic parameters even when total calories and macronutrients are appropriate for weight; 2) the timing of energy intake is an independent determinant of the diurnal rhythm of leptin secretion, indicating a relatively acute affect of energy balance on leptin dynamics; 3) the mechanism of exaggerated insulin secretion after a binge meal remains to be determined, but may be related to the altered diurnal pattern of leptin secretion; and 4) as most binge eating episodes in the population are associated with the ingestion of excess calories, it is hypothesized that binge eating behavior is associated with even greater metabolic dysfunction than that described herein. (J Clin Endocrinol Metab 84: 428 434, 1999) as anorexia nervosa and bulimia nervosa, but few studies have evaluated the consequences of binge eating alone. There are several potential mechanisms by which binge eating may cause or contribute to obesity. First, frequent binge meals would result in excess caloric ingestion, but a compensatory change in basal energy expenditure is not observed (11). Second, even if total calories were normal, the ingestion of fewer large meals may be metabolically worse than the ingestion of frequent small meals. Although the ingestion of six or nine small meals in a day has previously been demonstrated to reduce insulin secretion compared to the ingestion of three calorie- and nutrient-matched meals (12 14), the effects of a single daily meal, as is frequently observed in bingers and in many allegedly healthy Americans, has not previously been determined. If insulin levels are further increased by bingeing, they may contribute to increased hunger (15). Finally, recent studies suggest that the adipocyte hormone leptin could modify the response to binge eating. Serum leptin levels demonstrate a diurnal rhythm with a peak in the middle of the night (16, 17) when most humans are not eating and a nadir first thing in the morning. Fasting results in a gradual decline in leptin levels, first observed after 6 8 h (18). Thus, modulation of the diurnal pattern of leptin secretion by the timing of meals might have important implications for modulation of hunger. In addition to potential metabolic effects, binge eating is 428

METABOLIC IMPACT OF BINGE EATING 429 hypothesized to have effects on the hypothalamic-pituitarygonadal axis. For example, an increase in serum insulin levels may increase ovarian androgen secretion (19, 20) and/or modify pituitary gonadotropin secretion (21), thereby disrupting menstrual cyclicity. In addition, abolition of the diurnal pattern of leptin secretion is associated with amenorrhea in women athletes (22), suggesting that the leptin pattern is either a marker for or a response to a normal reproductive hormone axis. This study was designed to determine whether binge eating has adverse hormonal and metabolic effects. To study the effects of large meals per se independent of other potentially negative behaviors associated with bingeing, we studied lean normal women with regular ovulatory menstrual cycles and no history of eating disorders, who received meals that were matched for calorie and fat content. Subjects Subjects and Methods Seven lean normal Caucasian women with regular menstrual cycles participated in this study. Subjects were healthy with no medical illnesses and were taking no medications. Each had a history of regular 26- to 32-day menstrual cycles. Ovulation was documented in the luteal phase before the study by a serum progesterone level greater than 6 ng/dl. Subjects had no history of eating disorders and no evidence of a current eating disorder based on the BITE Edinburgh Bulimic Investigation Test questionnaire (23, 24). All subjects had normal TSH and PRL levels. The protocol was approved by the Massachusetts General Hospital Subcommittee on Human Studies, and all subjects gave their informed consent. Protocol Each subject was admitted to the Massachusetts General Hospital twice between 0800 1000 h in the early to midfollicular phase (cycle days 1 7) during two different menstrual cycles separated by less than 3 months. Each admission lasted for 3 days, during which all caloric ingestion was monitored and controlled. During one admission, subjects received three meals a day and an afternoon snack, with 20% of calories at 0800 h for breakfast, 30% of calories at noon for lunch, 10% of calories at 1500 h for a snack, and the remaining 40% of calories at 1800 h for dinner. During the other admission, in random order, subjects received 100% of calories at 1800 h, with nothing but water and noncaloric, noncaffeinated beverages the rest of the day. For both diets, total calories were individually adjusted to maintain weight and were matched between studies of the same individual, and macronutrients were distributed as 50 55% carbohydrate, 35 40% fat, and 10 15% protein. Twenty-four-hour collections of urine were obtained each day for measurements of creatinine, cortisol, and catecholamines (epinephrine, norepinephrine, and dopamine) as monitors of stress during the admissions. On the third day (after 48 h of the test diet), each subject had blood sampled from 0800 h every 15 min for insulin and leptin and every 30 min for glucose. The first three women underwent 12 h of frequent sampling until 2000 h, but the sampling window was extended to 2200 h (14 h) for the remainder of the subjects, as glucose levels had not fallen to baseline by 2000 h after the 1800 h meal. At 0800 h on the fourth day, fasting blood was obtained for serum insulin, glucose, lipid, and androgen determinations before an insulin tolerance test. Regular human insulin (0.1 U/kg) was administered iv, and blood samples were obtained at 5, 0, 3, 5, 7, 10, and 15 min for measurement of glucose (25, 26). The insulin tolerance test was terminated by administration of iv glucose and/or the immediate ingestion of breakfast before discharge. After each discharge, each subject obtained a daily blood sample until ovulation was documented by urinary LH kits (Sure Step Ovulation Predictor, Applied Biotech, Inc., San Diego, CA). The ovulation date of the first cycle was used to predict menses and schedule the second admission on a similar cycle day as the first. Subjects were requested to take oral iron replacement (ferrous gluconate, 300 mg daily or twice daily) from the time of acceptance into the study until completion of the menstrual cycle of the second study. Assays Glucose was measured by the glucose hexokinase method. Insulin was measured by an automated immunometric assay with a sensitivity of 1.0 IU/L and intra- and interassay coefficients of variation of 3% and 6 12%, respectively. Leptin was measured by a RIA (Linco Research, Inc. St. Charles, MO) with a sensitivity of 0.5 ng/ml and intra- and interassay coefficients of variation of 4.5 6% and 6.1 8.5%, respectively. Urinary free cortisol was measured in a coated tube RIA (Incstar Corp., Stillwater, MN) after methylene chloride extraction. Urinary catecholamines were measured by Nichols Institute Diagnostics (San Juan Capistrano, CA). LH, FSH, estradiol, progesterone, testosterone, androstenedione, 17-hydroxyprogesterone, and dehydroepiandrosterone sulfate were measured by in-house RIAs as previously described (27). Cholesterol was measured by peroxidase-phenol-4-amino phenazone modified Trinder method, triglycerides by peroxidase enzymatic reaction, and high density lipoprotein and low density lipoprotein were measured by an enzymatic, colorimetric, nonprecipitate method. All lipids were measured using Boehringer Mannheim reagents (Indianapolis, IN) on a Hitachi Scientific Instruments 917 machine (Hialeah, FL). Statistical analysis Fasting glucose, insulin, and leptin on day 3 and fasting glucose, insulin, androgens, and lipids on day 4 were compared between diets by paired t testing. Mean levels of glucose, insulin, and leptin for the frequent sampling sessions were determined by averaging the individual samples and were compared by paired t testing. Similarly, mean levels of glucose and insulin were determined and compared for the window after the evening meal (1815 to 2000 or 2000 h). Lastly, glucose, insulin, and leptin levels across the day were compared by ANOVA for repeated measures. Insulin sensitivity was estimated from the glucose disappearance rate (K itt ), which was calculated from the slope of the fall in glucose after insulin administration (26). The day of the LH surge was determined by using three of the following four criteria: the day of the peak LH, the day of the peak FSH, the day of or the day after the estradiol peak, and the day that progesterone doubled or exceeded 0.6 ng/ml (28). The day of the LH surge and the day of onset of menses were used to determine follicular and luteal phase lengths for each subject. LH, FSH, and estradiol levels were centered to the day of ovulation for each subject and meaned between subjects. In addition, classic statistical methods for cross-over study designs were employed to demonstrate that there was no effect of diet order on any of the variables tested (29). Results Patient characteristics The mean subject age was 28.1 3.0 yr (range, 19 40 yr) and the mean body mass index was 22.1 0.9 kg/m 2 (range, 20.5 25.9). The mean height was 162.2 cm (range, 150 170.5). During the normal diet, the mean body weight was 57.6 1.0 kg on day 1 and 56.6 1.0 kg on day 4 (P 0.01, by paired t test). On the binge diet, the mean weight was 57.1 1.1 kg on day 1 and 56.6 1.0 kg on day 4 (P 0.18). However, there was no significant difference in weights on the last day of the two diets. Metabolic characteristics Mean glucose and insulin levels over the 12 h of frequent sampling on the third day of the diets are shown for the normal and binge diets in Fig. 1. On the normal diet, glucose and insulin rose as expected after each meal and gradually declined after dinner. On the binge diet, glucose and insulin

430 TAYLOR, HUBBARD, AND ANDERSON JCE&M 1999 Vol 84 No 2 FIG. 1. Mean glucose and insulin levels ( SEM) from 0800 2200 h during the normal (open circles) and binge (filled circles) diets. Inverted triangles identify each time point at which levels are significantly different between the two diets, based on paired t testing. TABLE 1. Lipids and androgens Normal Binge Mean SEM Mean SEM Paired, two-sided t test (P value) Total cholesterol (mg/dl) 176.7 9.9 173.8 13.7 0.36 Triglycerides (mg/dl) 77.9 8.1 82.8 7.9 0.94 HDL cholesterol (mg/dl) 54.6 3.3 58.0 4.2 0.29 LDL cholesterol (mg/dl) 106.4 7.5 99.3 9.5 0.24 Testosterone (ng/dl) 77.0 14.1 63.2 7.2 0.22 17-Hydroxy progesterone (ng/ml) 1.4 0.4 1.1 0.3 0.54 Androstenedione (ng/ml) 4.8 0.6 4.5 0.5 0.55 DHEA-S ( g/ml) 188.5 22.0 174.1 24.1 0.52 Follicular phase length (days) 13.8 1.9 15.2 1.3 0.68 levels fell gradually across the day, rising after the evening meal. Fasting glucose was significantly higher on the binge diet on both days 3 and 4 (day 3: normal, 86 2 mg/dl; binge, 94 2 mg/dl; P 0.003). The mean glucose level across the duration of the study was significantly lower in the binge patients because they did not have postprandial increases after breakfast and lunch (normal mean, 107 2; binge, 97 2 mg/dl; P 0.003). However, the glucose response to the evening meal (sum glucose from 1815 2200 h) was remarkably similar between the two diets (normal, 896 48; binge, 879 80 mg/dl; P 0.37) considering that more than twice as many calories were ingested for the binge dinner. Fasting insulin levels were not significantly different on either the third or fourth day of either diet (normal, 3.5 0.8; binge, 3.6 1.1 U/mL; P 0.89). Similarly, the mean insulin levels from the entire frequent sampling study did not differ between the diets (normal, 13.0 2.1; binge, 13.1 2.4 U/mL; P 0.94). However, the insulin response to the evening meal (sum of insulin measurements from 1815 2200 h) was strikingly increased after the binge dinner (normal, 258.2 49; binge, 559.0 122.4 U/mL; P 0.01) despite virtually identical glucose responses. The glucose responses to the insulin tolerance test were similar on the fourth day of the two diets, suggesting that there was no difference in insulin sensitivity. The K itt was 3.2 0.2 U after the normal diet and 3.6 0.4 after the binge diet (P 0.145). The binge diet did not result in any significant difference in fasting lipid levels by the fourth day of the diet (Table 1). Leptin The two diets resulted in strikingly different patterns of leptin secretion across the third day (Fig. 2). In each individual, serum leptin levels were consistently higher than baseline by 8 h after the initiation of breakfast on the normal diet and continued to rise at the end of the frequent sampling (Fig. 3). Conversely, during the binge diet, leptin levels continued to fall throughout the day and had not begun to rise by 2200 h. Thus, although there was no significant difference in fasting levels (normal, 9.9 1.7; binge, 11.6 2.2 ng/ml; P 0.29) between the two diets, the mean leptin levels across the third day were significantly lower on the binge diet (normal, 11.3 1.8; binge, 8.9 1.6 ng/ml; P 0.04). From

METABOLIC IMPACT OF BINGE EATING 431 FIG. 2. Leptin levels as a percentage of fasting levels during the normal diet ( SEM) from 0800 2200 h during the normal (open circles) and binge (filled circles) diets. Inverted triangles identify each time point at which levels are significantly different between the two diets, based on paired t testing. 1800 2200 h, leptin averaged 45% lower on the binge diet than on the normal diet (P 0.005). Individual leptin secretion profiles from each individual (Fig. 3) demonstrate a pulsatile pattern of leptin secretion in all subjects. Menstrual cyclicity There was no significant difference in follicular or luteal phase length after 3 days of either diet (Table 1). After centering daily hormone levels to the day of ovulation, the patterns of gonadotropin and sex steroid secretion were indistinguishable after 3 days of either diet (data not shown). Finally, there was no difference in day 4 testosterone, 17- hydroxyprogesterone, androstenedione, or dehydroepiandrosterone sulfate (Table 1) between the two diets. Urine collections The data for urinary catecholamines, cortisol, creatinine, and volume are shown in Table 2. Although there was no difference in urine volume, creatinine, or catecholamine excretion between the first and second admissions, there was a small effect of admission order on total urinary free cortisol, such that cortisol excretion was higher during the first admission (52 9 vs. 43 6 g/24 h for admission 1 vs. 2, respectively; P 0.03). Although urine volume and creatinine and cortisol excretion were similar during the two diets, dopamine excretion was significantly greater during the binge diet (normal, 258 33; binge, 397 63 g/24 h; P 0.001). Discussion The present studies demonstrate that the ingestion of a single large daily meal results in metabolic changes in glucose, insulin, and leptin secretion. These findings are present in the healthiest subset of individuals, lean normal women without a history of eating disorders or menstrual dysfunction, and occurred without the ingestion of excess calories or excess fat. Fasting glucose was increased 8.4 0.2% on the binge compared to the normal diet. In addition, the insulin response to the binge evening meal was dramatically increased (108 29%) compared to the insulin response to the normal dinner. Previous studies have demonstrated that the ingestion of three meals a day results in higher total insulin levels than does the ingestion of six or nine small meals across the day (12 14). The current study, even given the limitation of sampling only for 12 14 h, demonstrates that this trend extends to even a single daily meal. The mechanism of hyperinsulinemia after the binge meal in these normal subjects remains to be determined. Although the doubling of insulin levels in response to similar glucose levels raises the possibility that there is insulin resistance, the insulin tolerance test the next morning does not confirm this. However, we cannot exclude the possibility that there is acute insulin resistance after the evening meal that is resolved by the overnight fast. In addition, the insulin tolerance test may not be a sufficiently sensitive test to identify significant changes in insulin sensitivity in this normal population. In these studies, the increased insulin response to the binge dinner occurs without an increased glucose response compared to the normal dinner, raising the possibility that the observed hyperinsulinemia does not represent insulin resistance but, rather, an increase in other insulin secretagogues or a decrease in insulin suppressers. Glucagon-like peptide-1 (GLP-1) is a physiologically important regulator of insulin secretion that is itself secreted from the pancreas in response to oral, but not iv, glucose in a dose-dependent manner (30). Administration of increasing doses of exogenous GLP-1 stimulates increased insulin secretion up to 40% over the baseline (31, 32). Thus, increased GLP-1 secretion may explain part of the increased insulin response to the binge meal.

432 TAYLOR, HUBBARD, AND ANDERSON JCE&M 1999 Vol 84 No 2 FIG. 3. Individual leptin profiles during the normal (left) and binge (right) diets. The two diets for each individual are shown in the same row. During the normal diet, leptin levels rise gradually across the day in all subjects, whereas they tend to fall during the binge diet. The vertical dotted lines represent meal times during the two calorie-matched diets. Pulsatile leptin secretion can be observed in all subjects, but is more pronounced in those with higher basal leptin levels. TABLE 2. 24-h urine collections Admission order Diet Admit 1 Admit 2 P Normal Binge P Epinephrine ( g/24 h) 3.62 (0.51) 2.95 (0.79) 0.18 3.70 (0.87) 3.47 (0.87) 0.64 Norepinephrine ( g/24 h) 23.05 (2.46) 19.29 (2.46) 0.13 21.43 (2.87) 24.58 (3.15) 0.22 Total catecholamines ( g/24 h) 27.14 (2.78) 24.13 (2.82) 0.27 23.81 (3.13) 27.48 (3.76) 0.17 Dopamine ( g/24 h) 321.7 (32.1) 275.5 (46.3) 0.22 258.1 (32.8) 396.6 (62.9) 0.001 Creatinine (mg/24 h) 1024.0 (60.3) 1006.9 (121.4) 0.92 1105.9 (145.8) 1103.1 (53.7) 0.96 Urinary free cortisol ( g/24 h) 52.00 (8.51) 42.91 (6.25) 0.03 44.01 (8.96) 50.89 (8.03) 0.11 Vol (ml) 1628.8 (123.8) 1684.5 (185.6) 0.75 1779.76 (262.62) 1533.52 (244.29) 0.14 Values are means (SEM). Leptin may also influence insulin secretion. In ambient glucose conditions, physiological leptin administration suppresses insulin secretion from rat islet cells or a human islet cell line (33). During the binge diet, leptin levels were 45% lower at the time of the evening meal compared to those during the normal diet. Thus, decreased leptin may also contribute to the increased insulin response to the binge meal. A diurnal rhythm of leptin has previously been described (16) and has been postulated by some to be related to the cortisol diurnal rhythm (34 36). Our studies demonstrate that the pattern of food ingestion itself is an important factor

METABOLIC IMPACT OF BINGE EATING 433 controlling the leptin secretion profile, even when total 24-h cortisol excretion is constant. The current study design could not detect any potential change in the cortisol diurnal rhythm, however. In this study in which meal timing has been carefully controlled for 3 days, leptin secretion begins to increase approximately 6 h after food ingestion, a more acute response than may have been appreciated in previous studies. Careful circadian studies in which sleep, position, and caloric intake are constant for at least 24 h will be required to determine whether the entire diurnal rhythm of leptin is merely secondary to the pattern of food ingestion or whether there is also an underlying circadian rhythm that might reflect other circadian neuroendocrine rhythms. In addition, it will be critical to determine whether the leptin diurnal rhythm can be modulated by the timing of food intake, as opposed to the amount, as recent studies of women athletes demonstrate that a flattened leptin diurnal rhythm is one of the few parameters that distinguish amenorrheic from eumenorrheic subjects (22). Such studies suggest that the pattern of leptin secretion across the day may have profound reproductive implications. Preliminary data from other studies of similar subjects in whom blood sampling continues for a full 24 h (Taylor, A. E., unpublished) suggest that a leptin diurnal rhythm is still maintained, although phase shifted, during binge eating. This is consistent with recent studies demonstrating a change in the leptin diurnal rhythm in response to simulated jet lag, even before the cortisol rhythm changed significantly (37). Thus, it may not be surprising that 3 days of binge eating were insufficient to induce a significant change in follicular or luteal phase length in the lean healthy young women. Whether modification of the pattern of caloric intake, with or without caloric restriction, will induce a physiologically significant flattening of the leptin diurnal rhythm remains to be determined. Our studies confirm the pulsatile nature of leptin secretion (34, 38), which is visible even when serum is sampled as infrequently as every 15 min. However, recent reports that leptin pulses typically occur approximately every 30 min (38) suggests that the sampling frequency for detecting the true frequency of pulsatile leptin secretion should be at least once every 5 min. This estimate is based on previous evidence that sampling frequency should be 6 times the interpulse interval (39). Because the sampling protocol employed in this study was suboptimal, formal pulse analysis was not performed. However, by visual inspection of Fig. 3, it appears that leptin pulsatile secretion is modulated by dietary intake, with an increase in pulse amplitude as overall leptin levels are also rising. The use of a more frequent sampling regimen will be required to determine whether pulse frequency changes with meals. The urine measurements of volume, creatinine, cortisol, and catecholamines were intended as a control for stress responses and metabolic balance during the 3 days of hospitalization and dietary control. As the development of obesity has been correlated with decreased sympathetic outflow in many experimental models (40), it was critical to demonstrate that bingeing did not exert its effects through modulation of epinephrine and norepinephrine excretion. Although there was a statistically significant increase in cortisol excretion during the first admission, the absolute magnitude was small and well within the normal range, making it unlikely to be physiologically relevant. Importantly, there was no difference in cortisol excretion between the two diets. However, there was a striking increase in urinary dopamine excretion during the binge diet. Increased dopamine excretion has been associated with insulin resistance (41) and hypertension (42) in different populations, suggesting that it may be a true marker of an adverse outcome of binge eating. As the urine collections were for the full 24 h, whereas blood sampling only lasted for 12 14 h, the increased urinary dopamine secretion with the binge diet suggests that the exaggerated insulin secretion persisted throughout the night. In summary, the ingestion of a single large daily meal has metabolic consequences, including increased fasting glucose levels, increased insulin responses to the binge meal, and modulation of the leptin diurnal rhythm. These factors, demonstrated here in young healthy lean women, are likely to be exacerbated in individuals who are already obese or insulin resistant. Because hyperinsulinemia has been associated with many adverse health outcomes, including an increased risk of cardiovascular disease, hypertension, and dyslipidemia, further studies are required to determine the long term consequences of the common practice of eating large evening meals. Acknowledgments We are grateful to Brain McCourt and Brooke Wexler for recruiting and managing the subjects and data for this complex protocol, and to the nurses on the Mallinkrodt General Clinical Research Center for their fastidious care of our subjects. References 1. Health and Public Policy Committee, American College of Physicians. 1986 Eating disorders: anorexia nervosa and bulimia. Ann Intern Med. 105:790 794. 2. Adami GF, Gandolfo P, Scopinaro N. 1996 Binge eating in obesity. Int J Obesity. 20:793 794. 3. Ferguson, KJ; Spitzer, RL. 1995 Binge eating disorder in a community-based sample of successful and unsuccessful dieters. Int J Eating Disord. 18:167 172. 4. Bruce, B; Wilfley, D. 1996 Binge eating among the overweight population: a serious and prevalent problem. J Am Diet Assoc. 96:58 61. 5. Berkowitz R, Stunkard AJ, Stallings VA. 1993 Binge-eating disorder in obese adolescent girls. Ann NY Acad Sci. 699:200 206. 6. Kurtzman FD, Yager J, Landsverk J, Wiesmeier E, Bodurka DC. 1989 Eating disorders among selected female student populations at UCLA. J Am Diet Assoc. 89:45 53. 7. Smith MC, Sundhaus E, Porzelius LK. 1995 Effect of binge eating on the prediction of weight loss in obese women. J Behav Med. 18:161 168. 8. Stancin T, Link DL, Reuter JM. 1989 Binge eating and purging in young women with IDDM. Diabetes Care. 12:601 603. 9. Wing RR, Nowalk MP, Marcus MD, Koeske R, Finegold D. 1986 Subclinical eating disorders and glycemic control in adolescents with type I diabetes. Diabetes Care. 9:162 167. 10. McCluskey SE, Lacey JH, Pearce JM. 1992 Binge-eating and polycystic ovaries [Letter]. Lancet. 340:723. 11. Alger S, Seagle H, Ravussin E. 1994 Food intake and energy expenditure in obese female bingers and non-bingers. Int J Obesity. 19:11 16. 12. Jones PJH, Leitch CA, Pederson RA. 1993 Meal-freqeuncy effects on plasma hormone concentrations and cholesterol synthesis in humans. Am J Clin Nutr. 57:868 874. 13. Arnold LM, Ball MJ, Duncan AW, Mann J. 1993 Effect of isoenergetic intake of three or nine meals on plasma lipoproteins and glucose metabolism. Am J Clin Nutr. 57:446 451. 14. Jenkins DJA, Wolever TMS, Vuksan V, et al. 1989 Nibbling vs. gorging: metabolic advantages of increased meal frequency. N Engl J Med. 321:929 934. 15. Stricker EM. 1984 Biological bases of hunger and satiety: therapeutic implications. Nutr Rev. 42:333 340. 16. Sinha MK, Ohannesian JP, Heiman ML, et al. 1996 Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest. 97:1344 1347. 17. Pombo M, Herrera-Justiniano E, Considine RV, et al. 1997 Nocturnal rise of

434 TAYLOR, HUBBARD, AND ANDERSON JCE&M 1999 Vol 84 No 2 leptin in normal prepubertal and pubertal children and in patients with perinatal stalk-transection syndrome. J Clin Endocrinol Metab. 82:2751 2753. 18. Boden G, Chen X, Mozzoli M, Ryan I. 1996 Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 81:3419 3423. 19. Barbieri RL, Makris A, Ryan KJ. 1984 Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca. Obstet Gynecol. 64:735. 20. Hernandez ER, Resnick CE, Svoboda ME, Van Wyk JJ, Payne DW, Adashi EY. 1988 Somatomedin-C/insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells. Endocrinology. 122:1603 1612. 21. Adashi EY, Hsueh AJW, Yen SSC. 1981 Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology. 108:1441 1449. 22. Laughlin GA, Yen SSC. 1996 Nutritional and endocrine-metabolic aberrations in amenorrheic athletes. J Clin Endocrinol Metab. 81:4301 4309. 23. Henderson M, Freeman CPL. 1987 A self-rating scale for bulimia: the BITE. Br J Psychol. 150:18. 24. Freeman CPL, Henderson M. 1988 The BITE: indices of agreement. Br J Psychol. 152:575. 25. Bonora E, Moghetti P, Zancanaro C, et al. 1989 Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab. 68:374 378. 26. Grulet H, Durlach V, Hecart AC, Gross A, Leutenegger M. 1993 Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index. Diabetes Res Clin Pract. 20:201 207. 27. Taylor AE, McCourt B, Martin KA, et al. 1997 Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:2248 2256. 28. Filicori M, Santoro N, Merriam GR, Crowley Jr WF. 1986 Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab. 62:1136 1144. 29. Armitage P, Hills M. 1982 The two-period crossover trial. Statistician. 31:119 131. 30. Habener JF. 1993 The Incretin Notion and its relevance to diabetes. Endocrinol Metab Clin North Am. 22:775 794. 31. Nathan DM, Schreiber E, Fogel H, Mojsov S, Habener JF. 1992 Insulinotropic action of glucagonlike peptide-1-(7 37) in diabetic and nondiabetic subjects. Diabetes Care. 15:270 276. 32. Elahi D, McAloon-Dyke M, Fukagawa NK, et al. 1994 The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagonlike peptide-1 (7 37) in normal and diabetic subjects. Regul Pept. 51:63 74. 33. Kieffer TJ, Heller RS, Leech CA, Holz GG, Habener JF. 1997 Leptin suppression of insulin secretion by the activation of ATP-sensitive K channels in pancreatic -cells. Diabetes. 46:1087 1093. 34. Licinio J, Mantzoros C, Negrao AB, et al. 1997 Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med. 3:575 579. 35. Korbonits M, Trainer PJ, Little JA, et al. 1997 Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin Endocrinol (Oxf). 46:751 757. 36. Dagogo-Jack S, Selke G, Melson AK, Newcomer JW. 1997 Robust leptin secretory response to dexamethasone in obese subjects. J Clin Endocrinol Metab. 82:3230 3233. 37. Schoeller DA, Cella LK, Sinha MK, Caro JF. 1997 Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest. 100:1882 1887. 38. Sinha MK, Sturis J, Ohannesian J, et al. 1996 Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun. 228:733 738. 39. Filicori M, Flamigni C, Crowley Jr WF. 1987 The critical role of blood sampling frequency in the estimation of episodic luteinizing hormone secretion in normal women. In: Crowley Jr WF, Hofler JG, eds. The episodic secretion of hormones. New York: Wiley and Sons; 5 13. 40. Bray GA, York DA. 1979 Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev. 59:719 809. 41. Young JB, Troisi RJ, Weiss ST, Parker DR, Sparrow D, Landsberg L. 1992 Relationship of catecholamine excretion to body size, obesity, and nutrient intake in middle-aged and elderly men. Am J Clin Nutr. 56:827 834. 42. Saito I, Itsuji S, Takeshita E, et al. 1994 Increased urinary dopamine excretion in young patients with essential hypertension. Clin Exp Hypertension. 16:29 39.